Translational Research in Head and Neck Oncology
Head and Neck Cancer(2016)
摘要
Translational research in head and neck oncology has evolved dramatically. Ongoing discoveries in basic mechanisms of cancer
biology and technological advances in both diagnostic imaging and radiation delivery have enhanced the ability to improve
treatment outcomes. The overarching goal for all translational research should be to enlarge the armamentarium from which
clinicians can rationally select the most appropriate options for individual patients in ways that maximize therapeutic benefit
and minimize toxicity. Focusing on this goal will become more critical as the health care system deals with external economic,
social, and political pressures and forces that will affect both bench and bedside. As these concerns encroach on the translational
process, it is imperative to recognize that the research itself is best equipped to address them – more efficacious treatments,
improved patient selection, decreased toxicity. What also should not be lost in translation is the unpredictable and occasional
serendipitous nature of research. Two cornerstones of head and neck cancer therapy, cisplatin [1, 2] and cetuximab, owe their
existence to chance and fate. Meanwhile, the compelling story of tumor hypoxia has yet to result in any new additions to the
therapeutic arsenal. This chapter will explore the meaning of translational research means, identify potential pitfalls on
the horizon, and highlight common themes and new avenues of research using specific examples from both the head and neck and
general oncology literature.
更多查看译文
关键词
translational researchoncologytargeted therapycetuximab
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要